Aker BioMarine to restructure finances
AKER BioMarine, the biotech innovator and Antarctic krill harvesting company, is planning to restructure its finances next month after reporting a somewhat flat third-quarter performance.
The company will hold a Capital Markets Day on 1 December, when it will outline its strategy to improve growth and earnings.
Aker said it had agreed on a new financing structure with its current bank group and one new bank entering the syndicate.
Total offshore production was 7,195 metric tonnes for the quarter, 17% below the same period last year.The season ended in the first week of October when the last vessel left for maintenance and upgrades in Montevideo, Uruguay.
Aker BioMarine has reported an adjusted EBITDA of US$15m (£11m), against $27m (£19.8m) for Q3 2020.
The company’s net turnover fell by $8m to $62m (£45.4m) while net profit was positive at $13.5m (£9.9m). Net cash flow was also positive at $7.3m (£5.3m).